scholarly journals Current Advances in Burkholderia Vaccines Development

Cells ◽  
2020 ◽  
Vol 9 (12) ◽  
pp. 2671
Author(s):  
Guanbo Wang ◽  
Paulina Zarodkiewicz ◽  
Miguel A. Valvano
Keyword(s):  
Burkholderia Cepacia ◽  
Burkholderia Pseudomallei ◽  
Vaccine Development ◽  
Respiratory Infections ◽  
Bacterial Species ◽  
Antimicrobial Treatment ◽  
Burkholderia Cepacia Complex ◽  
Attractive Alternative ◽  
Wide Range ◽  
Substantial Progress

The genus Burkholderia includes a wide range of Gram-negative bacterial species some of which are pathogenic to humans and other vertebrates. The most pathogenic species are Burkholderia mallei, Burkholderia pseudomallei, and the members of the Burkholderia cepacia complex (Bcc). B. mallei and B. pseudomallei, the cause of glanders and melioidosis, respectively, are considered potential bioweapons. The Bcc comprises a subset of Burkholderia species associated with respiratory infections in people with chronic granulomatous disease and cystic fibrosis. Antimicrobial treatment of Burkholderia infections is difficult due to the intrinsic multidrug antibiotic resistance of these bacteria; prophylactic vaccines provide an attractive alternative to counteract these infections. Although commercial vaccines against Burkholderia infections are still unavailable, substantial progress has been made over recent years in the development of vaccines against B. pseudomallei and B. mallei. This review critically discusses the current advances in vaccine development against B. mallei, B. pseudomallei, and the Bcc.

scholarly journals Comparison of Microbiological Characteristics and Genetic Diversity between Burkholderia cepacia Complex Isolates from Vascular Access and Other Clinical Infections

2020 ◽  
Vol 9 (1) ◽  
pp. 51
Author(s):  
Min Yi Wong ◽  
Yuan-Hsi Tseng ◽  
Tsung-Yu Huang ◽  
Bor-Shyh Lin ◽  
Chun-Wu Tung ◽  
...  
Keyword(s):  
Genetic Diversity ◽  
Vascular Access ◽  
Burkholderia Cepacia ◽  
Bacterial Species ◽  
Diversity Indices ◽  
Burkholderia Cepacia Complex ◽  
Reca Gene ◽  
Clinical Effects ◽  
Environmental Distribution ◽  
Microbiological Characteristics

Burkholderia cepacia complex (BCC) is a group of closely related bacteria with widespread environmental distribution. BCC bacteria are opportunistic pathogens that cause nosocomial infections in patients, especially cystic fibrosis (CF). Multilocus sequence typing (MLST) is used nowadays to differentiate species within the BCC complex. This study collected 41 BCC isolates from vascular access infections (VAIs) and other clinical infections between 2014 and 2020. We preliminarily identified bacterial isolates using standard biochemical procedures and further conducted recA gene sequencing and MLST for species identification. We determined genetic diversity indices using bioinformatics software. We studied 14 isolates retrieved from patients with VAIs and observed that Burkholderia cepacia was the predominant bacterial species, and B. contaminans followed by B. cenocepacia were mainly retrieved from patients with other infections. According to MLST data, we identified that all B. contaminans isolates belonged to ST102, while a wide variety of sequence types (STs) were found in B. cenocepacia isolates. In summary, the high diversity and easy transmission of BCC increase BCC infections, which provides insights into their potential clinical effects in non-CF infections.

scholarly journals Conservation of resistance nodulation cell division efflux pump mediated antibiotic resistance in Burkholderia cepacia complex and Burkholderia pseudomallei complex species

2021 ◽  
Author(s):  
Nawarat Somprasong ◽  
Jinhee Yi ◽  
Carina M. Hall ◽  
Jessica R. Webb ◽  
Jason W. Sahl ◽  
...  
Keyword(s):  
Cell Division ◽  
Burkholderia Cepacia ◽  
Burkholderia Pseudomallei ◽  
Efflux Pump ◽  
Multidrug Resistant ◽  
Resistance Mechanisms ◽  
Burkholderia Cepacia Complex ◽  
Complex Species ◽  
Functional Studies ◽  
Rnd Efflux Pump

Burkholderia cepacia complex (Bcc) and Burkholderia pseudomallei complex (Bpc) species include pathogens that are typically multidrug resistant. Dominant intrinsic and acquired multidrug resistance mechanisms are efflux mediated by pumps of the resistance nodulation cell division (RND) family. From comparative bioinformatic and, in many instances, functional studies we infer that RND pump-based resistance mechanisms are conserved in Burkholderia . We propose to use these findings as a foundation for adoption of a uniform RND efflux pump nomenclature.

scholarly journals Misidentification of Burkholderia pseudomallei and Other Burkholderia Species From Pediatric Infections in Mexico

2019 ◽  
Vol 6 (2) ◽  
Author(s):  
Georgina Meza-Radilla ◽  
Ausel Mendez-Canarios ◽  
Juan Xicohtencatl-Cortes ◽  
Marcos R Escobedo-Guerra ◽  
Alfredo G Torres ◽  
...  
Keyword(s):  
New Species ◽  
Burkholderia Cepacia ◽  
Burkholderia Pseudomallei ◽  
Burkholderia Cepacia Complex ◽  
Burkholderia Species ◽  
Genotypic Analysis ◽  
Pediatric Infections

Abstract Burkholderia pseudomallei and Burkholderia cepacia complex are poorly studied in Mexico. The genotypic analysis of 38 strains isolated from children with pneumonia were identified and showed that both Burkholderia groups were present in patients. From our results, it is plausible to suggest that new species are among the analyzed strains.

scholarly journals Identification of Burkholderia cepacia complex bacteria with a lipopolysaccharide-specific monoclonal antibody

2010 ◽  
Vol 59 (1) ◽  
pp. 41-47 ◽  
Author(s):  
David P. AuCoin ◽  
Reva B. Crump ◽  
Peter Thorkildson ◽  
Dana E. Nuti ◽  
John J. LiPuma ◽  
...  
Keyword(s):  
Burkholderia Cepacia ◽  
Burkholderia Pseudomallei ◽  
Proteinase K ◽  
Burkholderia Cepacia Complex ◽  
Gram Negative Bacteria ◽  
Specific Monoclonal Antibody ◽  
Separate Species ◽  
Gram Negative ◽  
Ladder Pattern ◽  
Human Infections

The genus Burkholderia includes many bacteria that cause serious human infections. As is the case with other Gram-negative bacteria, Burkholderia species produce LPS, which is an abundant component of the bacterial cell surface. Burkholderia cepacia complex (Bcc) bacteria (which include at least 17 separate species) produce LPS structures that are quite different. In an attempt to determine the degree of LPS epitope variation among Bcc species, a mAb was produced, designated 5D8, specific for the LPS of B. cepacia. Western blot analysis determined that mAb 5D8 was able to produce the classic ‘ladder pattern’ when used to probe B. cepacia and Burkholderia anthina lysates, although 5D8 did not produce this pattern with the other seven Bcc species tested. mAb 5D8 reacted with varying intensity to most but not all of the additional B. cepacia and B. anthina strains tested. Therefore, there seems to be significant epitope variation among Bcc LPS both between and within species. Additionally, mAb 5D8 reacted with a proteinase-K-sensitive 22 kDa antigen in all Bcc strains and also in a strain of Burkholderia pseudomallei.

scholarly journals Burkholderia cepacia Complex Bacteria: a Feared Contamination Risk in Water-Based Pharmaceutical Products

2020 ◽  
Vol 33 (3) ◽  
Author(s):  
Mariana Tavares ◽  
Mariya Kozak ◽  
Alexandra Balola ◽  
Isabel Sá-Correia
Keyword(s):  
Burkholderia Cepacia ◽  
Bacterial Species ◽  
Public Health Problem ◽  
Pharmaceutical Products ◽  
Health Care Facilities ◽  
Burkholderia Cepacia Complex ◽  
Pseudomonas Cepacia ◽  
Environmental Distribution ◽  
Content Type ◽  
Metabolic Versatility

SUMMARY Burkholderia cepacia (formerly Pseudomonas cepacia) was once thought to be a single bacterial species but has expanded to the Burkholderia cepacia complex (Bcc), comprising 24 closely related opportunistic pathogenic species. These bacteria have a widespread environmental distribution, an extraordinary metabolic versatility, a complex genome with three chromosomes, and a high capacity for rapid mutation and adaptation. Additionally, they present an inherent resistance to antibiotics and antiseptics, as well as the abilities to survive under nutrient-limited conditions and to metabolize the organic matter present in oligotrophic aquatic environments, even using certain antimicrobials as carbon sources. These traits constitute the reason that Bcc bacteria are considered feared contaminants of aqueous pharmaceutical and personal care products and the frequent reason behind nonsterile product recalls. Contamination with Bcc has caused numerous nosocomial outbreaks in health care facilities, presenting a health threat, particularly for patients with cystic fibrosis and chronic granulomatous disease and for immunocompromised individuals. This review addresses the role of Bcc bacteria as a potential public health problem, the mechanisms behind their success as contaminants of pharmaceutical products, particularly in the presence of biocides, the difficulties encountered in their detection, and the preventive measures applied during manufacturing processes to control contamination with these objectionable microorganisms. A summary of Bcc-related outbreaks in different clinical settings, due to contamination of diverse types of pharmaceutical products, is provided.

scholarly journals Aerosol Phage Therapy Efficacy in Burkholderia cepacia Complex Respiratory Infections

2014 ◽  
Vol 58 (7) ◽  
pp. 4005-4013 ◽  
Author(s):  
Diana D. Semler ◽  
Amanda D. Goudie ◽  
Warren H. Finlay ◽  
Jonathan J. Dennis
Keyword(s):  
Intraperitoneal Injection ◽  
Burkholderia Cepacia ◽  
Phage Therapy ◽  
Respiratory Infections ◽  
Burkholderia Cepacia Complex ◽  
Resistant Bacteria ◽  
Antibiotic Resistant ◽  
Content Type ◽  
Therapy Efficacy

ABSTRACTPhage therapy has been suggested as a potential treatment for highly antibiotic-resistant bacteria, such as the species of theBurkholderia cepaciacomplex (BCC). To address this hypothesis, experimentalB. cenocepaciarespiratory infections were established in mice using a nebulizer and a nose-only inhalation device. Following infection, the mice were treated with one of fiveB. cenocepacia-specific phages delivered as either an aerosol or intraperitoneal injection. The bacterial and phage titers within the lungs were assayed 2 days after treatment, and mice that received the aerosolized phage therapy demonstrated significant decreases in bacterial loads. Differences in phage activity were observedin vivo. Mice that received phage treatment by intraperitoneal injection did not demonstrate significantly reduced bacterial loads, although phage particles were isolated from their lung tissue. Based on these data, aerosol phage therapy appears to be an effective method for treating highly antibiotic-resistant bacterial respiratory infections, including those caused by BCC bacteria.

Sign in / Sign up

Export Citation Format

Share Document